Healthcare Innovator Ronald Amodeo Joins Dorsey Health Strategies in Minneapolis

MINNEAPOLIS, MN––(December 6, 2018)––International law firm Dorsey & Whitney LLP is pleased to announce that Ronald Amodeo has joined the Firm as an Expert Advisor with Dorsey Health Strategies (DHS), a healthcare consulting firm affiliated with Dorsey & Whitney.  

Mr. Amodeo was previously the Chief Innovation & Growth Officer at Regional Health in South Dakota, where he was responsible for developing and executing strategies related to business growth in the marketplace, service line enhancement, connected health, innovation, and new ventures and partnerships/collaborations.  He was also responsible for Marketing and Sales, Patient Experience, Community Relations, Clinical Research, and developing new revenue streams.  

Prior to his work at Regional Health, Mr. Amodeo was Director of Business Development at Mayo Clinic, where he led enterprise-wide evaluation and development of strategic new business opportunities. Key projects included directing joint venture activities in retail health/wellness, regenerative medicine, and remote condition management via digital health. International projects included developing a medical tourism venture in Asia, as well as business initiatives/relationships in India, Ireland, U.K., Saudi Arabia, UAE and the Czech Republic.

Mr. Amodeo has a Bachelor of Science degree in Biology from Allegheny College, a Master’s degree in Information Design from Carnegie Mellon University and Ph.D. studies in History of Science and Technology from the University of Minnesota.  

“Ron brings a wealth of healthcare expertise and experience that will benefit our health industry clients and Dorsey Health Strategies,” noted Ross D’Emanuele, Partner and Co-chair of Dorsey’s Healthcare Industry Group. “The health industry is in the midst of a wave of innovations and Ron’s deep experience in new business and product development strategy and execution will help address those challenges and opportunities.”

“Ron has real-world experience as an executive leader in the health industry, and he brings his boots-on-the-ground mentality, combined with his breadth of experience, in a way that helps our clients immensely.  His practical expertise allows him to quickly connect the dots between strategy and execution needs, and he has a keen sense for what different health industry players need,” noted Shira Hauschen, Managing Principal of Dorsey Health Strategies.  “We are delighted to welcome him to the Dorsey Health Strategies team.”

About Dorsey & Whitney LLP and Dorsey Health Strategies LLC

Clients have relied on Dorsey since 1912 as a valued business partner. With locations across the United States and in Canada, Europe and the Asia-Pacific region, Dorsey provides an integrated, proactive approach to its clients' legal and business needs. Dorsey represents a number of the world's most successful companies from a wide range of industries, including leaders in banking & financial institutions, development & infrastructure, energy & natural resources, food, beverage & agribusiness, healthcare and technology, as well as major non-profit and government entities.  

As part of its mission to stay “always ahead” of industry trends, Dorsey offers business consulting services to health industry clients to help plan for the future, manage current change, and stay compliant with health industry federal, state, and local regulations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.